PDE1 inhibitor compounds
US9371327B2 · kind B2 · utility
10Cited by
23References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2011 |
| Grant date | Jun 21, 2016 |
| Priority date | — |
| Expiry date | Sep 28, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to optionally substituted (5- or 7-oxy)-3,4-dihydro-(optionally 4-oxo, 4-thioxo or 4-imino)-1H-pyrrolo[3,4-d]pyrimidin-2(3H,6H)-ones, e.g., Compounds of Formula II-A′ or II-B′ as described herein, processes for their production, their use as pharmaceuticals and pharmaceutical compositions comprising them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.